Effective January 1, 2017, Philips Lighting will split from existing Plan Sponsor, Philips Electronics (RXGRP RX0146). Please update or create plan member profiles to reflect the changes regarding the following new plan adjudicating through CVS Caremark.

*Please see attached PDF for more information.

*Please see attached PDF for more information.

Effective 01/01/2017 majority of the drugs with quantity limits will be switching from Period To Date (PTD) logic to Max Daily dose (MDD) logic. PTD Quantity is used to set limitations on the quantity received within a period of time specified. If the member has not exceeded the maximum quantity within that time frame, they are eligible to receive the drug. MDD quantity is the maximum number of units of the drug allowed per day.

If rejection is received please verify that the day supply submitted on the claim is correct. If the allowed max daily dose is truly exceeded, please communicate this information to the patient and/or physician so the physician may initiate the prior authorization request as needed.

You should have received a notice on Thursday of last week that announced that the latest data update was made available in EQuIPP on Thursday, December 15th. 

As you start to explore your dashboards this month, we wanted to follow-up on our Service Notice from Friday to let you know that most of the updates to your EQuIPP performance information completed on Friday. One data provider is continuing to be updated throughout the day today (Monday, December 19th). As a result of the updates, you may notice a change in your performance information for the new measurement period and potentially a brief disruption in the presentation of your EQuIPP Dashboard.